| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $655K | +63.9% |
| SG&A Expense | $3.2M | -20.8% |
| Operating Income | -$6.7M | -20.7% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$6.9M | +48.8% |
| Income Tax | $0 | — |
| Net Income | -$6.9M | +48.8% |
| EPS (Basic) | -$0.55 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $137 | +57.5% |
| Current Assets | $1.7M | -73.8% |
| Total Assets | $6.1M | -36.6% |
| Current Liabilities | $2.3M | +913.2% |
| Stockholders' Equity | $3.9M | -59.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | +13.1% |
| Capital Expenditures | $4K | -95.3% |
| Investing Cash Flow | -$1.9M | -24.4% |
| Financing Cash Flow | $2.0M | -84.9% |
| Free Cash Flow | -$4.8M | +14.3% |
| +57.7% |
| EPS (Diluted) | -$0.55 | +57.7% |